论文部分内容阅读
目的探讨临床路径管理在肺结核可疑患者中的实施效果。方法采用前瞻性追踪研究方法,对广州市越秀区200例肺结核可疑患者进行追踪,将200例可疑患者分为观察组100例和对照组100例,观察组采用肺结核可疑患者临床路径管理,对照组采用传统方法诊疗,分别从临床指标和经济学指标方面对两组的效果进行评估。结果两组确诊疾病差异无统计学意义(P>0.05)。观察组确诊时间较对照组明显缩短(P<0.01)。观察组直接医疗总费用及检查费较对照组减少(P<0.05),两组挂号费、药品费及其他治疗费用(雾化取痰费用)差异无统计学意义(P>0.05)。观察组进入路径时间为(11.21±5.86)d,完成路径率为97.0%,退出路径率为3.0%,变异率为34.0%。结论实施临床路径管理有利于早期发现肺结核患者及减轻患者负担,对控制结核病疫情具有重要意义。
Objective To explore the clinical path management in tuberculosis suspects in the implementation of the effect. Methods A prospective follow-up study was conducted in 200 cases of suspected tuberculosis patients in Yuexiu District of Guangzhou City. The 200 suspicious patients were divided into observation group (100 cases) and control group (100 cases). The observation group was treated with clinical pathological management of suspected tuberculosis patients and control group The traditional method of diagnosis and treatment, respectively, from the clinical indicators and economic indicators of the two groups to assess the effect. Results There was no significant difference in the two groups of diagnosed diseases (P> 0.05). The observation group was significantly shorter than the control group (P <0.01). There was no significant difference between the two groups in registration fees, medical expenses and other treatment costs (cost of atomization and sputum removal) (P> 0.05). The observation group’s entry time was (11.21 ± 5.86) d, the completion path rate was 97.0%, the exit path rate was 3.0% and the mutation rate was 34.0%. Conclusion The implementation of clinical path management is conducive to the early detection of tuberculosis patients and reduce the burden on patients, control of tuberculosis epidemic is of great significance.